Product Description & Research Overview
PT-141 (Bremelanotide) is an FDA-approved synthetic peptide that acts as a melanocortin receptor agonist. Unlike traditional erectile dysfunction medications such as sildenafil (Viagra) or tadalafil (Cialis), which work by increasing blood flow, PT-141 targets the central nervous system by activating pathways involved in sexual desire and arousal.
Because its mechanism is brain-based rather than vascular, PT-141 has been researched in both men and women experiencing reduced sexual desire, including individuals who do not respond adequately to conventional PDE5 inhibitors. It has received FDA approval for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women (Vyleesi®) and has also been investigated for male erectile dysfunction, female arousal disorder, and other disorders involving impaired sexual function.
Research continues to explore ways to optimize dosing, reduce nausea, and better understand PT-141’s role in supporting sexual function across a broader range of conditions. Unlike medications intended for daily use, PT-141 is typically studied as an as-needed therapy, with effects generally beginning within 45–90 minutes and lasting approximately 6–12 hours.
Research suggests PT-141 may enhance sexual arousal through several complementary mechanisms:
Timing: Best taken 45–60 minutes before sexual activity. May be taken with or without food, although food may help reduce nausea. Effects generally last 6–12 hours.
Reconstitution (10 mg Vial)
Step 1
Add 2.0 mL diluent.
Creates a 5.0 mg/mL solution.
Step 2
Draw 20 units for a 1 mg dose.
Quick Reference
Frequency: As needed
Doses per vial: 10 doses (at 1 mg per dose)
Approximate vial usage: 10 doses per vial
Disclaimer
For research use only. Not for human consumption.
The dosing information provided is intended solely for laboratory and research purposes and is not medical advice. Always consult qualified professionals regarding research protocols.
These statements have not been evaluated by Health Canada or the U.S. Food and Drug Administration (FDA).
Research suggests PT-141 may enhance sexual arousal through several complementary mechanisms:
Timing: Best taken 45–60 minutes before sexual activity. May be taken with or without food, although food may help reduce nausea. Effects generally last 6–12 hours.
Reconstitution (10 mg Vial)
Step 1
Add 2.0 mL diluent.
Creates a 5.0 mg/mL solution.
Step 2
Draw 20 units for a 1 mg dose.
Quick Reference
Frequency: As needed
Doses per vial: 10 doses (at 1 mg per dose)
Approximate vial usage: 10 doses per vial
Research suggests PT-141 may enhance sexual arousal through several complementary mechanisms:
Timing: Best taken 45–60 minutes before sexual activity. May be taken with or without food, although food may help reduce nausea. Effects generally last 6–12 hours.
Reconstitution (10 mg Vial)
Step 1
Add 2.0 mL diluent.
Creates a 5.0 mg/mL solution.
Step 2
Draw 20 units for a 1 mg dose.
Quick Reference
Frequency: As needed
Doses per vial: 10 doses (at 1 mg per dose)
Approximate vial usage: 10 doses per vial
